NARA Discovery
Article Details
← Back to Search Results
Journal Article

Pkhd1cyli/cyli mice have altered renal Pkhd1 mRNA processing and hormonally sensitive liver disease

Chaozhe Yang; Naoe Harafuji; Ljubica Caldovic; Weiying Yu; Ravindra Boddu; Surajit Bhattacharya; Hayk Barseghyan; Heather Gordish-Dressman; Oded Foreman; Zsuzsa Bebok; Eva M. Eicher; Lisa M. Guay-Woodford
Journal of Molecular Medicine · Vol. 101, Issue 9 · pp. 1141-1151 · 2023

Abstract

Autosomal-recessive polycystic kidney disease (ARPKD; MIM #263200) is a severe, hereditary, hepato-renal fibrocystic disorder that causes early childhood morbidity and mortality. Mutations in the polycystic kidney and hepatic disease 1 ( PKHD1 ) gene, which encodes the protein fibrocystin/polyductin complex (FPC), cause all typical forms of ARPKD. Several mouse lines carrying diverse, genetically engineered disruptions in the orthologous Pkhd1 gene have been generated, but none expresses the classic ARPKD renal phenotype. In the current study, we characterized a spontaneous mouse Pkhd1 mutation that is transmitted as a recessive trait and causes cysticliver ( cyli ), similar to the hepato-biliary disease in ARPKD, but which is exacerbated by age, sex, and parity. We mapped the mutation to Chromosome 1 and determined that an insertion/deletion mutation causes a frameshift within Pkhd1 exon 48, which is predicted to result in a premature termination codon (UGA). Pkhd1 cyli/cyli ( cyli ) mice exhibit a severe liver pathology but lack renal disease. Further analysis revealed that several alternatively spliced Pkhd1 mRNA, all containing exon 48, were expressed in cyli kidneys, but in lower abundance than in wild-type kidneys, suggesting that these transcripts escaped from nonsense-mediated decay (NMD). We identified an AAAAAT motif in exon 48 upstream of the cyli mutation which could enable ribosomal frameshifting, thus potentially allowing production of sufficient amounts of FPC for renoprotection. This mechanism, expressed in a species-specific fashion, may help explain the disparities in the renal phenotype observed between Pkhd1 mutant mice and patients with PKHD1 -related disease. Key messages The Pkhd1 cyli/cyli mouse expresses cystic liver disease, but no kidney phenotype. Pkhd1 mRNA expression is decreased in cyli liver and kidneys compared to wild-type. Ribosomal frameshifting may be responsible for Pkhd1 mRNA escape from NMD. Pkhd1 mRNA escape from NMD could contribute to the absent kidney phenotype.

Bibliographic Information

JournalJournal of Molecular Medicine
PublisherSpringer
Publication Date2023-09-01
Publication Year2023
Volume101
Issue9
Pages1141-1151
Document TypeJournal Article
Print ISSN0946-2716
eISSN1432-1440
DOI10.1007/s00109-023-02351-2

Access Information

NARA Access Coverage1922-01-01~Current
Journal Homepagehttps://www.springer.com/journal/109
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.